Astec LifeSciences accepts GM-HR resignation to pursue new role
Astec LifeSciences Limited accepted the resignation of Ms. Vijayalakshmi Iyer as General Manager – Human Resources effective June 5, 2026, to pursue a new opportunity. The company confirmed no other material reasons for the resignation.

*this image is generated using AI for illustrative purposes only.
Astec LifeSciences Limited has accepted the resignation of Ms. Vijayalakshmi Iyer from the position of General Manager – Human Resources. The resignation, tendered on June 5, 2026, was submitted to pursue a new opportunity and has been accepted by the Board of Directors. The company confirmed there are no other material reasons for the resignation beyond the stated career move.
The disclosure was made to the stock exchanges pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was signed by Tejashree Pradhan, Company Secretary & Compliance Officer, and submitted to BSE Limited and National Stock Exchange of India Limited.
Resignation Details
The following table outlines the key particulars of the cessation of the senior management personnel:
| Sr. No. | Particulars | Details |
|---|---|---|
| 1. | Reason for change | Resignation to pursue a new opportunity |
| 2. | Date of Cessation | June 5, 2026 |
| 3. | Brief Profile | Not Applicable |
| 4. | Disclosure of relationships | Not Applicable |
In her resignation letter, Ms. Iyer expressed her commitment to ensuring a smooth transition during her notice period. She stated she would work closely with the team to complete key deliverables and support the handover process effectively. She also extended her gratitude to the organization for the opportunities provided during her tenure.
Historical Stock Returns for Astec Lifesciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.75% | +0.04% | +14.47% | +1.39% | -0.59% | -44.32% |
Who will be appointed to succeed Ms. Iyer and what is the expected timeline for this transition?
How will this leadership change impact Astec LifeSciences' ongoing HR initiatives and talent retention strategies?
Will the company face any increased operational risks during the interim period before a new General Manager is onboarded?


































